2023
DOI: 10.21203/rs.3.rs-3170899/v1
|View full text |Cite|
Preprint
|
Sign up to set email alerts
|

WITHDRAWN: Association between serum C1q and the efficacy of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer

Abstract: Objective To evaluate the association between serum complement component 1q (C1q) and the efficacy of immune checkpoint inhibitors (ICIs) in patients with advanced non-small cell lung cancer (NSCLC). Methods Baseline characteristics and laboratory data of the patients with advanced NSCLC who received ICIs in the Renmin Hospital of Wuhan University from July 2018 to January 2023, were collected for the evaluation of survival analysis. The efficacy was estimated according to the response evaluation criteria in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 12 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?